US Broker Ratings

Owens & Minor (OMI) Stock Analysis: Navigating Healthcare Distribution with a 19.65% Upside Potential

Owens & Minor, Inc. (NYSE: OMI) stands as a pivotal player in the healthcare distribution sector, offering a comprehensive array of products and services through its..

Auna SA (AUNA) Stock Analysis: Navigating a 95.37% Upside Potential in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might find Auna SA (AUNA) an intriguing prospect. This Luxembourg-based company operates hospitals and clinics across Mexico, Peru,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a Complex Investment Landscape Amidst Impressive Revenue Growth

Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a notable player in the healthcare sector, particularly within the drug manufacturing industry for specialty and generic pharmaceuticals...

Xeris Biopharma Holdings (XERS): Investor Outlook with a 21.86% Potential Upside

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a prominent player in the healthcare sector, is making waves in the biotechnology industry with its innovative therapies aimed at..

Akso Health Group (AHG) Stock Analysis: Unpacking the 676% Revenue Surge in China’s Medical Distribution Sector

Akso Health Group (NASDAQ: AHG) has been making waves in the healthcare sector, particularly in the niche of medical distribution in China. With a market cap..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Unveiling a Potential 71.89% Upside

Investors with an eye on the biotechnology sector should take note of Stoke Therapeutics, Inc. (NASDAQ: STOK), a promising player in the field of genetic disease..

Zevra Therapeutics, Inc. (ZVRA): Analyst Consensus Points to Nearly 95% Upside Potential

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is making waves in the biotechnology sector with its focus on developing treatments for rare diseases. Headquartered in Celebration, Florida, this..

Rocket Pharmaceuticals (RCKT) Stock Analysis: Exploring a Potential 171% Upside in the Gene Therapy Space

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is captivating the attention of investors with its ambitious gene therapy pipeline and a compelling potential upside of 171.03%. As a..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring a 100% Upside Potential

Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the healthcare sector, stands out in the medical devices industry with its innovative ultrasound imaging solutions. Headquartered..

Fulgent Genetics (FLGT) Stock Analysis: Unveiling a 23% Potential Upside in the Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT), a key player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents an intriguing investment opportunity for those..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unveiling a 205.50% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC) is capturing investor attention with its innovative approach in the biotechnology sector. Based in Cambridge, United Kingdom, this clinical-stage pharmaceutical company..

ArriVent BioPharma, Inc. (AVBP) Investor Outlook: Analyzing an 87.52% Potential Upside

ArriVent BioPharma, Inc. (AVBP) is capturing attention in the biotechnology sector with its promising clinical-stage projects focused on addressing unmet medical needs in cancer treatment. As..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Harnessing a 96.95% Potential Upside in Biotechnology

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is steadily capturing investor attention within the biotechnology sector, boasting a compelling potential upside of nearly 97%. Headquartered in Waltham, Massachusetts,..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 54% Upside Potential

Investors in the biopharmaceutical space might find Theravance Biopharma, Inc. (NASDAQ: TBPH) a compelling opportunity, given the company’s significant potential upside. With a market capitalization of..

Taysha Gene Therapies, Inc. (TSHA): Investor Outlook Reveals Stunning 222% Potential Upside

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is capturing the attention of investors with its cutting-edge approach to treating monogenic diseases of the central nervous system through..

Ardelyx, Inc. (ARDX) Stock Analysis: Exploring the 148% Potential Upside in Biotechnology

Ardelyx, Inc. (NASDAQ: ARDX), a key player in the biotechnology sector, presents an intriguing opportunity for investors seeking growth in the healthcare industry. With a market..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 277% Upside Potential in Biotech

Relay Therapeutics, Inc. (NASDAQ: RLAY), a prominent player in the biotechnology sector, is capturing investor attention with its significant growth potential. With a market capitalization of..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 64% Upside Potential

Embecta Corp. (EMBC) is gaining attention in the investment community, not only for its contributions to the healthcare sector but also for its significant potential upside..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A Potential 203.95% Upside in Biotech

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands at the forefront of the biotechnology sector, making significant strides in the development of cell therapies for cancer treatment. With..

Weave Communications, Inc. (WEAV)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds